SmartPharm Therapeutics

About:

SmartPharm Therapeutics is a second-generation gene-encoded therapeutics company.

Website: https://smartpharmtx.com/

Twitter/X: smartpharmtx

Description:

SmartPharm Therapeutics is a second-generation gene-encoded therapeutics company that has benefited from the first decades of learning in gene therapy development to produce an evolved therapeutic platform. They integrate these insights with key technologies and engineering capabilities to enable them to produce optimal gene-encoded therapeutics for patients. SmartPharm is focused on “gene-encoded therapeutics”. It is a subset of gene therapy that seeks to insert nucleic acids (mRNA or DNA) into cells to make normal versions of a missing or abnormal program or to produce an entirely new type of protein that has therapeutic benefit.

Total Funding Amount:

$10.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)smartpharmtx.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2018-01-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai